Botanicals for the prevention and treatment of cutaneous melanoma

被引:21
|
作者
Syed, Deeba N. [1 ]
Mukhtar, Hasan [1 ]
机构
[1] Univ Wisconsin, Dept Dermatol, Madison, WI 53715 USA
关键词
botanicals; melanoma; DIFFERENTIATION-INDUCING ACTIVITY; GENISTEIN INHIBITS GROWTH; CELLS IN-VITRO; FACTOR-KAPPA-B; MALIGNANT-MELANOMA; UP-REGULATION; GREEN TEA; ANTIANGIOGENIC ACTIVITY; ULTRAVIOLET-RADIATION; SILYMARINS PROTECTION;
D O I
10.1111/j.1755-148X.2011.00851.x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Cutaneous melanoma, a cancer of melanocytes, when detected at later stages is arguably one of the most lethal cancers and the cause of more years of lost life than any other cancer among young adults. There is no standard therapy for advanced-stage melanoma and the median survival time for patients with metastatic melanoma is <1 yr. An urgent need for novel strategies against melanoma has directed research towards the development of new chemotherapeutic and biologic agents that can target the tumor by several different mechanisms. Recently, several dietary agents are being investigated for their role in the prevention and treatment of various forms of cancer and may represent the future modality of the treatment. Here, we have reviewed emerging data on botanicals that are showing promise for their potential inhibitory effect against cutaneous melanoma.
引用
收藏
页码:688 / 702
页数:15
相关论文
共 50 条
  • [41] Electrochemotherapy as Treatment of Cutaneous and Subcutaneous Melanoma Metastases
    Ruggeri, R.
    Patuzzo, R.
    Gallino, G.
    Maurichi, A.
    Camerini, T.
    Mattavelli, I
    Crippa, F.
    Moglia, D.
    Tolomio, E.
    Santinami, M.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2013, 11 : 53 - 53
  • [42] Erratum to: Progression of cutaneous melanoma: implications for treatment
    Stanley P. L. Leong
    Martin C. Mihm
    George F. Murphy
    Dave S. B. Hoon
    Mohammed Kashani-Sabet
    Sanjiv S. Agarwala
    Jonathan S. Zager
    Axel Hauschild
    Vernon K. Sondak
    Valerie Guild
    John M. Kirkwood
    Clinical & Experimental Metastasis, 2012, 29 (7) : 797 - 799
  • [43] Cutaneous melanoma in the elderly: epidemiology, prognosis and treatment
    Lasithiotakis, Konstantinos G.
    Petrakis, Ioannis E.
    Garbe, Claus
    MELANOMA RESEARCH, 2010, 20 (03) : 163 - 170
  • [44] Topical imiquimod treatment of a cutaneous melanoma metastasis
    Steinmann, A
    Funk, JO
    Schuler, G
    von den Driesch, P
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2000, 43 (03) : 555 - 556
  • [45] Treatment of periocular cutaneous melanoma in situ with imiquimod
    O'Donnell, Olivia
    Guitera, Pascale
    Gouveia, Bruna
    O'Donnell, Brett
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2023, 51 (09): : 941 - 942
  • [46] Photodynamic therapy in treatment of cutaneous and choroidal melanoma
    Kawczyk-Krupka, Aleksandra
    Bugaj, Andrzej M.
    Latos, Wojciech
    Zaremba, Katarzyna
    Sieron, Aleksander
    PHOTODIAGNOSIS AND PHOTODYNAMIC THERAPY, 2013, 10 (04) : 503 - 509
  • [47] CUTANEOUS HEAD AND NECK MELANOMA - DIAGNOSIS AND TREATMENT
    BALM, AJM
    KROON, BBR
    DIAGNOSTIC ONCOLOGY, 1993, 3 (05): : 233 - 233
  • [48] What's new in the treatment of cutaneous melanoma?
    Olhoffer, IH
    Bolognia, JL
    SEMINARS IN CUTANEOUS MEDICINE AND SURGERY, 1998, 17 (02) : 96 - 107
  • [49] Cutaneous Melanoma with Tonsillar Metastasis: Treatment with Cryoablation
    Dulskas, Audrius
    Trakymas, Mantas
    Gibaviciene, Jolita
    Epulis, Vytautas
    Cizauskaite, Agne
    Samalavicius, Narimantas E.
    ACTA MEDICA LITUANICA, 2022, 29 (01) : 118 - 123
  • [50] Current state of treatment for primary cutaneous melanoma
    Chung, ES
    Sabel, MS
    Sondak, VK
    CLINICAL AND EXPERIMENTAL MEDICINE, 2004, 4 (02) : 65 - 77